4//SEC Filing
ORTH ANDREW C. 4
Accession 0001860010-23-000002
CIK 0001711279other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:45 PM ET
Size
9.0 KB
Accession
0001860010-23-000002
Insider Transaction Report
Form 4
ORTH ANDREW C.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-28+20,000→ 20,000 totalExercise: $81.91Exp: 2033-02-28→ Common Stock (20,000 underlying) - Award
Performance Stock Units
2023-02-28+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Holdings
- 100
Common Stock
Footnotes (5)
- [F1]The option vests in four equal annual installments beginning on February 28, 2024.
- [F2]Each performance stock unit ("PSU") represents a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement.
- [F3]The number of PSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming achievement of all of the corporate performance criteria set by the Company's Compensation Committee for this award.
- [F4]If any applicable portion of the performance criteria have been achieved, the award shall vest in two equal annual installments (February 28, 2024 and February 28, 2025).
- [F5]If the performance criteria are not achieved, the portion of the award which was capable of vesting on that date will expire.
Documents
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
Related Parties
1- filerCIK 0001860010
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:45 PM ET
- Size
- 9.0 KB